JP Patent

JP5462168B2 — Ｎ−（５−ｔｅｒｔ−ブチル−イソオキサゾール−３−イル）−Ｎ’−｛４−［７−（２−モルホリン−４−イル−エトキシ）イミダゾ［２，１−ｂ］［１，３］ベンゾチアゾール−２−イル］フェニル｝ウレアを含む固形、その組成物、及びその用途

Assigned to アムビト ビオスシエンセス コルポラチオン · Expires 2014-04-02 · 12y expired

What this patent protects

Patent listed against quizartinib-dihydrochloride.

Drugs covered by this patent

Patent Metadata

Patent number
JP5462168B2
Jurisdiction
JP
Classification
—
Expires
2014-04-02
Drug substance claim
No
Drug product claim
No
Assignee
アムビト ビオスシエンセス コルポラチオン
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.